Digital Therapeutics Alliance Announces Partnership to Strategize European Market Access
A new alliance of digital therapeutics (DTx) industry groups is hoping that by partnering together they can help create synergies between the regulatory pathways in the United States and Europe.
The Digital Therapeutics Alliance (DTA), a Virginia-based trade group of digital therapeutics developers and stakeholders, this month announced a partnership with the Healthware Group, a European firm that provides advisory and technology services to digital therapeutics companies. The two groups will hold their first in-person meeting at the Frontiers Health Global Conference in October, they said.
“The primary goal of the DTA/Healthware collaboration to develop a pan-European coalition is to bring decision makers together to discuss what may be the best path forward to ensure safe and effective DTx therapies can be accessible to patients regardless of where they live,” said Megan Coder, Pharm.D., MBA, the chief policy officer at alliance.
Keep reading it at www.managedhealthcareexecutive.com